Private Equity Acquisition and Access to Reti...

Retina is producing Phase 3 results faster than ever, but FDA approval doesn't necessarily convey how a drug will fit into practice. Dr. Ehsan Rahimy joins host Dr. Jay Sridhar to unpack recent and somewhat puzzling trial results involving tyrosine kinase inhibitors, IL-6 inhibit ...  Show more

Artificial intelligence is rapidly recasting how we interact with our world and our patients. In today's epside, host Dr. Amanda Redfern welcomes Dr. Chris Kelly, Chief Health Information Officer at Oregon Health and Science University (OHSU), to provide an inside look at tools a ...  Show more

Dr. Matt Feng interviews Drs. Bita Momenaei and Jason Hsu on the incidence, timing, risk factors, and outcomes of recurrent retinal detachment after phacoemulsification, from their Ophthalmology Retina article, "<a href= "https://www.ophthalmologyretina.org/a ...

Dr. Rajesh Rao discusses the increasing cost and lack of Medicare reimbursement of vitrectomy surgery with Dr. Shriji Patel from his 2021 Ophthalmology Retina article, "Cost Analysis of Routi ...

Dr. Rajesh Rao dives deep into world of retinal implants with author Dr. Mark Humayun from his Ophthalmology Retina article, "Advanced Retina Implants."

Don't miss Oph ...